Senior Medical Strategy Director, Prostate Cancer - Remote

Sumitomo Pharma; Phoenix (AZ); Remoto; USD 191.000 - 239.000; Tempo pieno

Descrizione del lavoro

Sumitomo Pharma America, Inc. is seeking an Associate Director of Medical Strategy (Prostate Cancer) to lead medical strategy and scientific communication for prostate cancer programs.

The role partners with the Medical Affairs Director and cross-functional teams to develop strategies, publications, and external engagements in a fast-paced, regulated environment. Responsibilities include directing medical affairs plans, collaborating with field medical, HEOR, publications, and external experts,

Competenze

• Strong understanding of Medical Affairs strategy and publication planning.
• Experience in oncology and medical communications.
• Ability to lead cross-functional projects in a regulated environment.

Mansioni

• Serve as medical director for assigned prostate cancer projects with leadership responsibility.
• Develop Medical Affairs strategic plans aligned with brand goals and external engagement.
• Coordinate with cross-functional partners to support education, publications, and congress activities.
• Provide input to R&D and collaborate with external scientific experts and alliance partners.
• Oversee investigator-initiated and collaborative research programs and budget planning.

Conoscenze

Medical strategy

Cross-functional leadership

Scientific communications

Publication planning

Evidence generation

Regulatory compliance

Formazione

PhD/MD/DO/PharmD or equivalent

Descrizione del lavoro

Sumitomo Pharma America, Inc. is seeking an Associate Director of Medical Strategy (Prostate Cancer) to lead medical strategy and scientific communication for prostate cancer programs.

The role partners with the Medical Affairs Director and cross-functional teams to develop strategies, publications, and external engagements in a fast-paced, regulated environment. Responsibilities include directing medical affairs plans, collaborating with field medical, HEOR, publications, and external experts,